CHMP Recommends EU Approval of Bimekizumab for Plaque Psoriasis June 29, 2021 Auto Bot News 0 EMA’s CHMP has adopted a positive opinion recommending the approval of UCB’s bimekizumab (Bimzelx) for the treatment of plaque psoriasis.